The Joe Rogan ExperienceJoe Rogan Experience #1615 - Hamilton Morris
CHAPTERS
- 0:00 – 2:08
Catching up in the new Texas studio: the ‘red tube’ setup
Joe and Hamilton reunite and joke about their earlier, overly-stoned episode before talking about the evolution of Rogan’s podcast studios. Joe explains the rushed move from LA to Texas and what he’d change in the current studio design.
- •Third time on the podcast (with a nod to the unusable first recording)
- •Rogan’s move to Texas and building a studio in five weeks
- •Why the red-and-black ‘tube’ design feels visually odd
- •Joe’s desire to keep iterating on the studio layout
- 2:08 – 4:04
Brooklyn in winter COVID: garbage, closures, and the mental toll
Hamilton describes New York—especially Brooklyn—as the grimmest he has ever seen it during the pandemic winter. They compare the decline to what Joe observed in Los Angeles before leaving.
- •NYC’s shutdown effects: cold, impaired services, and worsening street conditions
- •Local businesses closing and a ‘dystopian’ atmosphere
- •Running as a coping strategy disrupted by ice and unsafe conditions
- •LA parallels: visible deterioration and rising homelessness
- 4:04 – 6:25
Homelessness, economic divides, and the Amazon package-theft ecosystem
The conversation turns to how cities are handling homelessness and the reality that shelters and rules often clash with addiction. Hamilton adds a snapshot of NYC’s ‘Amazon economy’ and the secondary market of stealing packages.
- •Why shelters’ no-drug policies push some unhoused people away
- •LA’s tent expansion and the logistical impossibility of ‘where do they go?’
- •NYC’s building-by-building flow of Amazon deliveries
- •Package theft as a predictable shadow economy
- 6:25 – 8:46
Lockdowns, restaurant collapse, and the moral argument over staying open
Joe argues that prolonged shutdowns ignore how hard it is for businesses to restart once savings and credit are gone. Hamilton explains the ethical tension in supporting restaurants while workers may feel pressured to take risks.
- •How business recovery requires capital that many no longer have
- •Claims about massive restaurant attrition (especially in LA)
- •NYC’s heated outdoor dining workarounds
- •Debate: supporting businesses vs incentivizing unsafe labor
- 8:46 – 11:39
Mask rules and ‘security theater’: contradictions on flights and retail
Hamilton describes his first flight of the pandemic and the oddity of universal masking while airlines still serve food and drinks. Joe broadens it into a critique of inconsistent policies across big-box stores versus small businesses.
- •Airplane masking breaks down during snack and water service
- •Crowded flights contradict the premise of social distancing
- •Policy inconsistency: Target/Walgreens allowed, small shops restricted
- •Masking as social signaling vs actual risk reduction
- 11:39 – 18:37
Immune health vs pharma fixes—and how COVID treatments got politicized
Joe argues public health messaging neglected nutrition, exercise, and metabolic health, while Hamilton stresses the need for strong evidence and the slow pace of medicine. Hamilton then explains how treatments like chloroquine became irrationally politicized.
- •Debate over vitamins (D, C), zinc/quercetin, and general health guidance
- •Obesity and comorbidities acknowledged but under-emphasized in messaging
- •Early-pandemic hope for antivirals vs vaccine timelines
- •Chloroquine/hydroxychloroquine as a case study in politicizing molecules
- 18:37 – 21:25
Leaving New York and leaving TV: Hamilton’s shift toward full-time chemistry
Hamilton considers moving (eventually to Philadelphia) because a lab he works with is there and he wants to focus on chemistry. He explains why producing his show became unsustainably difficult—especially during the pandemic.
- •Altucher’s ‘NYC is gone’ argument as context for relocation
- •Decision to move to Philadelphia for lab access
- •Why the show became financially and logistically punishing
- •What he learned from pandemic-era production constraints
- 21:25 – 32:17
Psychedelic research funding, neurogenesis claims, and microdosing skepticism
They discuss how psychedelic science is re-emerging due to new funding and institutional interest, including brain injury/CTE work. Hamilton cautions against simplistic ‘neurogenesis equals good’ narratives and notes mixed evidence around microdosing.
- •Past research slowed by lack of funding as much as government pressure
- •Pharma interest as a controversial but powerful driver of progress
- •Psilocybin and brain repair: promising but still early science
- •Microdosing studies showing placebo-level effects and dosing uncertainty
- 32:17 – 41:44
Forgotten drug history: ibogaine microdosing, Monaz, and black-market ecology
Hamilton shares historical examples of ‘microdosing-like’ medicines (Lambarene/ibogaine in France, Monaz in the U.S.) and why some were discontinued. They also detour into MDMA precursors and how prohibition incentivizes environmentally destructive supply chains.
- •Ibogaine sold as a stimulant in mid-century France (not as a psychedelic)
- •Alpha-ethyltryptamine (Monaz) as an antidepressant and why it ended
- •Cambodian saffrol deforestation as a black-market consequence
- •Alternate synthesis routes (including inefficient ‘black pepper’ pathways)
- 41:44 – 56:49
Drug stigma, Carl Hart, and the ‘music as medicine’ analogy for freedom
They defend Carl Hart’s openness about drug use as unusually brave and argue stigma worsens harm. Hamilton presents a long analogy: society could have treated music like drugs—illegal until ‘proven’ medically useful—missing the point of personal freedom.
- •Why honesty about drug use is rare in academic/professional circles
- •Stigma vs encouragement: reducing shame without promoting misuse
- •Freedom argument: adults shouldn’t need medical justification to choose
- •Medicalization can help legalization but can also distort the core principle
- 56:49 – 1:06:35
Nicotine, cigars, vaping, and the deeper issue of dependence
They light cigars and pivot to nicotine’s cultural role, comparing cigarettes, vaping, and nicotine gum. Hamilton emphasizes that even ‘non-destructive’ dependence can be disempowering, distinct from life-ruining addiction.
- •Cigarettes as a performance ritual vs long-term health reality
- •Vaping: regulated products vs unregulated ‘e-juice’ risks
- •Nicotine gum framed as safer but still highly addictive
- •Dependence as a loss of autonomy—even without catastrophic outcomes
- 1:06:35 – 1:24:45
Opioids beyond headlines: Narcan, withdrawal, tianeptine, and ‘opiophobia’
Hamilton argues opioid discussions swing between extremes and often ignore nuance: pharmacology, dosing, context, and the reality of withdrawal management. He tells the story of tianeptine’s concealed opioid activity, how Narcan precipitates withdrawal, and why fear of opioids can block legitimate research.
- •Responsibility in the opioid crisis: pharma, doctors, and patients
- •Narcan (naloxone): receptor displacement, instant withdrawal, re-overdose risk
- •Imodium (loperamide) as a peripheral opioid and an example of drug design
- •Tianeptine: marketed mechanism vs mu-opioid agonism and investor aversion
- 1:24:45 – 1:33:18
Drug hysteria and policing: the Charles Innis ‘PCP eye-gouging’ story reexamined
Hamilton recounts receiving an email from Charles Innis, the infamous ‘PCP made him tear out his eyes’ cautionary tale. Innis’ real account reframes it as entrapment and police neglect, illustrating how drug scares become scapegoats that mask structural abuses.
- •How a media ‘drug horror’ story became a cultural myth
- •Entrapment setup involving drug possession and a subsequent raid
- •Medical neglect during intoxication as the real driver of harm
- •Why stigma makes drugs an easy tool for dehumanization and control
- 1:33:18 – 1:43:27
Determinism, crack sentencing, and the fixable mechanics of prohibition
They connect drug policy to broader social injustice: crack vs cocaine disparities, poverty, and how ‘bad guy’ narratives simplify complex causes. Hamilton argues many real levers—sentencing, healthcare, education, and prohibition—are concrete and fixable compared to vague cultural slogans.
- •‘Good guy/bad guy’ policing mindset and determinism arguments
- •Crack vs powder cocaine: same drug, radically different penalties
- •Structural inequality and why ‘bootstrapping’ narratives collapse
- •Policy targets: prohibition, healthcare access, and sentencing reform
- 1:43:27 – 2:00:36
Ketamine, SSRIs, dissociatives vs psychedelics—and the toad venom conservation crisis
They explore how ketamine moved from ‘party drug’ to clinical depression treatment and why altered states may be therapeutically valuable rather than a side effect to eliminate. Hamilton also explains 5-MeO-DMT toad venom myths and the real conservation harm of ‘milking’ toads for a molecule available synthetically.
- •Ketamine vs PCP: chemical differences and experiential differences
- •SSRIs and the idea that ‘depression’ is many conditions, not one
- •5-MeO-DMT: synthetic vs venom—chemistry vs spiritual branding
- •Celebrity-driven demand (e.g., Tyson) influencing ecological outcomes
- 2:00:36 – 2:47:43
Benzodiazepines, Jordan Peterson’s withdrawal, xenon as an anesthetic ‘element drug,’ and Sci-Hub
Hamilton breaks down why benzodiazepines (like Xanax/Klonopin) can be uniquely difficult to stop—biologically and psychologically—using Peterson’s case as a reference point. He then introduces xenon as a rare psychoactive single element used as an anesthetic, before pivoting to Sci-Hub as a world-changing tool for open scientific access and a counterpoint to rage-driven internet culture.
- •Benzodiazepines: GABA-A modulation, rebound anxiety, tapering, seizure risk
- •Peterson as a high-stress outlier and how context shapes withdrawal severity
- •Xenon: heavy noble gas anesthetic with rapid ‘inhale/exhale unchanged’ profile
- •Sci-Hub’s impact: universal access to paywalled scientific literature and why it’s threatened
